ETV6 (Transcription factor ETV6) variants and mutations
ETV6 (also known as Transcription factor ETV6) is a human protein-coding gene encoding a transcription factor protein. It normally restrains hematopoietic transcriptional programs and is important for blood-cell development and vascular biology. Germline loss-of-function variants can cause thrombocytopenia with leukemia predisposition, while numerous ETV6 fusion genes drive leukemias and other cancers. This analysis covers 888 ETV6 variants and mutations. Of these, 71% have computational variant effect predictions. Disease context includes thrombocytopenia 5, Thrombocytopenia, and acute myeloid leukemia. Example ETV6 variants include S2S, E3D, and T4I.
Variant analysis overview
- Gene: ETV6
- Protein: Transcription factor ETV6
- UniProt accession: P41212
- Organism: Homo sapiens
- Variants analyzed: 888
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 728 unspecified-consequence records; 73 synonymous variants; 72 missense variants; 4 splice-region variants; 3 frameshift variants; 3 in-frame deletions; 1 stop lost; 1 stop-gained variants; 3 substitution
- Prediction scores: 634 variants have prediction scores (71% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: thrombocytopenia 5, Thrombocytopenia, acute myeloid leukemia, cancer, hereditary disease, acute lymphoblastic leukemia, Abnormality of the skeletal system, hematopoietic and lymphoid system neoplasm, Abnormal bleeding, myeloproliferative neoplasm, chronic myelogenous leukemia, BCR-ABL1 positive, congenital fibrosarcoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 8 post-translational modification sites.
- Structural context: 187 variants have structural context.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ETV6 variants
Examples include S2S, E3D, T4I, T4S, P5P, A6D, A6V, Q7H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2S (p.Ser2Ser), rs1863862351, gnomAD 12-11650133-T-C, CADD 14.60
- E3D (p.Glu3Asp), ExAC rs752535111, gnomAD rs752535111, REVEL 0.10, CADD 19.30
- T4I (p.Thr4Ile), ExAC rs777712463, gnomAD rs777712463, REVEL 0.11, CADD 21.70, Likely benign, Inborn genetic diseases
- T4S (p.Thr4Ser), ExAC rs758276152, gnomAD rs758276152, REVEL 0.08, CADD 18.10
- P5P (p.Pro5Pro), gnomAD 12-11650142-T-G, CADD 14.30
- A6D (p.Ala6Asp), rs1863862591, ClinGen CA384041922, ClinVar RCV003848731, ClinVar RCV005555059, REVEL 0.05, CADD 22.60, Conflicting interpretations, not provided; Inborn genetic diseases
- A6V (p.Ala6Val), NCI-TCGA Cosmic COSV6715, MetaLR 0.01, MetaSVM -0.97, Likely benign, Inborn genetic diseases
- Q7H (p.Gln7His), gnomAD rs1237008107, MetaLR 0.02, MetaSVM -1.02, Uncertain significance, Inborn genetic diseases
- Q7K (p.Gln7Lys), gnomAD rs1376185672, REVEL 0.07, CADD 18.70
- Q7R (p.Gln7Arg), gnomAD 12-11650147-A-G, REVEL 0.09, CADD 19.60
- Q7Q (p.Gln7Gln), gnomAD 12-11650148-G-A, CADD 11.40
- C8F (p.Cys8Phe), rs921592943, ClinGen CA232479199, ClinVar RCV002912129, ClinVar RCV004725613, REVEL 0.06, CADD 22.10, Uncertain significance, Inborn genetic diseases; not provided
- C8S (p.Cys8Ser), gnomAD 12-11650150-G-C, REVEL 0.07, CADD 21.10
- C8C (p.Cys8Cys), rs1286400353, gnomAD 12-11650151-T-C, CADD 14.70
- S9N (p.Ser9Asn), Ensembl rs768354458, MetaLR 0.02, MetaSVM -1.00
- S9R (p.Ser9Arg), ESP rs372541278, ExAC rs372541278, gnomAD rs372541278, REVEL 0.09, CADD 21.80, Uncertain significance, Neoplasm
- I10N (p.Ile10Asn), TOPMed rs1425860852, REVEL 0.26, CADD 23.10, Uncertain significance, Inborn genetic diseases
- I10V (p.Ile10Val), Ensembl rs1242574618, REVEL 0.12, CADD 19.00, Likely benign, Inborn genetic diseases
- I10I (p.Ile10Ile), gnomAD 12-11650157-T-C, CADD 14.50
- K11E (p.Lys11Glu), Ensembl rs932279404, REVEL 0.10, CADD 23.30
- K11N (p.Lys11Asn), NCI-TCGA Cosmic COSV6715, MetaLR 0.02, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- K11K (p.Lys11Lys), rs547638904, gnomAD 12-11650160-G-A, CADD 25.20
- Q12R (p.Gln12Arg), gnomAD 12-11752451-A-G, REVEL 0.17, CADD 23.50
- Q12Q (p.Gln12Gln), rs757789814, gnomAD 12-11752452-G-A, CADD 14.60
- E13E (p.Glu13Glu), gnomAD 12-11752455-A-G, CADD 10.80
- R14* (p.Arg14Ter), gnomAD rs1475305922, CADD 37.00
- R14L (p.Arg14Leu), rs781494988, ClinGen CA6454097, ClinVar RCV003567759, ExAC rs781494988, REVEL 0.14, CADD 25.60, Uncertain significance, not provided
- R14Q (p.Arg14Gln), rs781494988, ClinGen CA6454096, NCI-TCGA Cosmic COSV6714, ClinVar RCV003333872, REVEL 0.11, CADD 23.50, Uncertain significance, not provided; Inborn genetic diseases
- R14R (p.Arg14Arg), rs1475305922, gnomAD 12-11752456-C-A, CADD 12.00
- I15V (p.Ile15Val), gnomAD 12-11752459-A-G, REVEL 0.02, CADD 15.50
- S16* (p.Ser16Ter), NCI-TCGA Cosmic COSV6715, Variant assessed as somatic; high impact.
- S16A (p.Ser16Ala), TOPMed rs1866050780, gnomAD rs1866050780, REVEL 0.12, CADD 22.80
- Y17C (p.Tyr17Cys), Ensembl rs2121067376, REVEL 0.10, CADD 24.30, Uncertain significance, Inborn genetic diseases
- Y17H (p.Tyr17His), rs746119985, ClinGen CA232546442, ClinVar RCV003877686, ClinVar RCV005325876, AlphaMissense 0.75, MetaLR 0.02, Uncertain significance, not provided; Inborn genetic diseases
- Y17Y (p.Tyr17Tyr), rs144055004, gnomAD 12-11752467-T-C, CADD 5.39
- T18I (p.Thr18Ile), ExAC rs754405842, gnomAD rs754405842, REVEL 0.08, CADD 23.60, Uncertain significance, Inborn genetic diseases
- T18T (p.Thr18Thr), rs1866050923, gnomAD 12-11752470-A-C, CADD 10.80
- P19H (p.Pro19His), NCI-TCGA Cosmic COSV6714, Variant assessed as somatic; moderate impact.
- P19S (p.Pro19Ser), rs2121067453, ClinGen CA384041491, NCI-TCGA Cosmic COSV1011, ClinVar RCV003712664, AlphaMissense 0.54, MetaLR 0.06, Uncertain significance, not provided
- P19T (p.Pro19Thr), rs2121067453, ClinGen CA384041487, ClinVar RCV001774206, ClinVar RCV005564899, REVEL 0.16, AlphaMissense 0.54, Uncertain significance, Inborn genetic diseases; not provided
- P19L (p.Pro19Leu), gnomAD 12-11752472-C-T, REVEL 0.19, CADD 26.40
- P19P (p.Pro19Pro), rs147305258, gnomAD 12-11752473-T-C, CADD 11.20
- P20S (p.Pro20Ser), NCI-TCGA Cosmic COSV6714, REVEL 0.13, CADD 17.70, Variant assessed as somatic; moderate impact.
- P20A (p.Pro20Ala), gnomAD 12-11752474-C-G, REVEL 0.10, CADD 20.20
- P20L (p.Pro20Leu), gnomAD 12-11752475-C-T, REVEL 0.15, CADD 22.80
- P20P (p.Pro20Pro), rs747866453, gnomAD 12-11752476-A-G, CADD 8.45
- E21G (p.Glu21Gly), rs139212214, ClinGen CA6454101, ClinVar RCV003441563, ESP rs139212214, REVEL 0.06, CADD 22.70, Uncertain significance, not provided
- E21V (p.Glu21Val), ESP rs139212214, ExAC rs139212214, TOPMed rs139212214, gnomAD rs139212214, REVEL 0.03, CADD 21.10, Likely benign, Inborn genetic diseases
- E21K (p.Glu21Lys), gnomAD 12-11752477-G-A, REVEL 0.11, CADD 23.00
- E21D (p.Glu21Asp), gnomAD 12-11752479-G-C, REVEL 0.04, CADD 21.30
- E21E (p.Glu21Glu), gnomAD 12-11752479-G-A, CADD 10.90
- S22C (p.Ser22Cys), NCI-TCGA Cosmic COSV6714, Variant assessed as somatic; moderate impact.
- S22I (p.Ser22Ile), TOPMed rs1300012416, gnomAD rs1300012416, REVEL 0.20, CADD 26.10, Uncertain significance
- S22N (p.Ser22Asn), TOPMed rs1300012416, gnomAD rs1300012416, REVEL 0.06, CADD 21.40, Conflicting interpretations, not provided; Inborn genetic diseases
- S22R (p.Ser22Arg), ESP rs373836023, ExAC rs373836023, TOPMed rs373836023, gnomAD rs373836023, MetaLR 0.03, MetaSVM -1.13
- S22T (p.Ser22Thr), gnomAD 12-11752481-G-C, REVEL 0.11, CADD 23.50
- S22S (p.Ser22Ser), rs373836023, gnomAD 12-11752482-C-T, CADD 9.16
- P23L (p.Pro23Leu), gnomAD 12-11752484-C-T, REVEL 0.14, CADD 25.50
- V24A (p.Val24Ala), TOPMed rs1424443413, gnomAD rs1424443413, REVEL 0.05, CADD 22.60
- V24M (p.Val24Met), Ensembl rs1866051588, REVEL 0.05, CADD 22.90, Uncertain significance, Inborn genetic diseases
- V24V (p.Val24Val), rs143194205, gnomAD 12-11752488-G-A, CADD 11.50
- P25L (p.Pro25Leu), rs550013624, ClinGen CA6454104, ClinVar RCV001357659, ClinVar RCV005330745, REVEL 0.03, CADD 21.10, Conflicting interpretations, Inborn genetic diseases; not provided
- P25Q (p.Pro25Gln), gnomAD 12-11752490-C-A, REVEL 0.04, CADD 22.70
- P25P (p.Pro25Pro), rs776389717, gnomAD 12-11752491-G-A, CADD 7.56
- S26P (p.Ser26Pro), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.05, Variant assessed as somatic; high impact.
- S26T (p.Ser26Thr), rs150858928, ClinGen CA6454106, ClinVar RCV001569071, ClinVar RCV004980600, REVEL 0.09, CADD 12.30, Conflicting interpretations, Inborn genetic diseases; not provided
- S26G (p.Ser26Gly), gnomAD 12-11752492-A-G, REVEL 0.04, CADD 18.70
- S26N (p.Ser26Asn), gnomAD 12-11752493-G-A, REVEL 0.09, CADD 11.00
- Y27N (p.Tyr27Asn), gnomAD 12-11752495-T-A, REVEL 0.08, CADD 22.10
- Y27F (p.Tyr27Phe), gnomAD 12-11752496-A-T, REVEL 0.04, CADD 19.70
- Y27Y (p.Tyr27Tyr), rs765354372, gnomAD 12-11752497-C-T, CADD 10.30
- A28D (p.Ala28Asp), ExAC rs763230765, gnomAD rs763230765, REVEL 0.04, CADD 17.00
- A28P (p.Ala28Pro), rs34966596, NCI-TCGA Cosmic COSV6715, ClinGen CA384041626, REVEL 0.04, CADD 13.80, Conflicting interpretations, Inborn genetic diseases; not provided
- A28R (p.Ala28Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A28S (p.Ala28Ser), ESP rs34966596, ExAC rs34966596, TOPMed rs34966596, gnomAD rs34966596, REVEL 0.09, CADD 5.70, Likely benign, Inborn genetic diseases
- A28T (p.Ala28Thr), rs34966596, ClinGen CA6454108, NCI-TCGA Cosmic COSV6715, REVEL 0.10, CADD 8.49, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- A28V (p.Ala28Val), gnomAD 12-11752499-C-T, REVEL 0.05, CADD 17.10
- S29Y (p.Ser29Tyr), gnomAD 12-11752502-C-A, REVEL 0.23, CADD 23.90
- S30A (p.Ser30Ala), rs1866052380, ClinGen CA384041654, ClinVar RCV003416725, ClinVar RCV005062885, AlphaMissense 0.07, MetaLR 0.11, Uncertain significance, not provided; Inborn genetic diseases
- S30L (p.Ser30Leu), rs764237239, ClinGen CA6454110, ClinVar RCV003248715, ClinVar RCV003730483, REVEL 0.16, CADD 24.00, Uncertain significance, Inborn genetic diseases; not provided
- S30P (p.Ser30Pro), gnomAD 12-11752504-T-C, REVEL 0.10, CADD 24.10
- S30S (p.Ser30Ser), rs1245345088, gnomAD 12-11752506-G-A, CADD 7.88
- T31M (p.Thr31Met), rs149994836, ClinGen CA6454111, ClinVar RCV001776504, ClinVar RCV003151351, REVEL 0.09, CADD 23.40, Uncertain significance, Inborn genetic diseases; not provided
- T31A (p.Thr31Ala), gnomAD 12-11752507-A-G, REVEL 0.06, CADD 20.30
- T31T (p.Thr31Thr), rs201801905, gnomAD 12-11752509-G-A, CADD 7.65
- P32P (p.Pro32Pro), gnomAD 12-11752512-A-G, CADD 5.51
- L33H (p.Leu33His), rs1555123823, ClinGen CA384041699, ClinVar RCV000520098, Ensembl rs1555123823, AlphaMissense 0.14, MetaLR 0.12, Uncertain significance, not provided
- L33I (p.Leu33Ile), ExAC rs756629283, gnomAD rs756629283, REVEL 0.13, CADD 22.90, Likely benign, Inborn genetic diseases
- H34L (p.His34Leu), TOPMed rs1437620013, Uncertain significance
- H34Q (p.His34Gln), rs767627393, ClinGen CA232546571, ClinVar RCV001768930, ClinVar RCV004980640, REVEL 0.16, CADD 21.00, Uncertain significance, Inborn genetic diseases; not provided
- H34R (p.His34Arg), rs1437620013, ClinGen CA384041707, ClinVar RCV003691057, TOPMed rs1437620013, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance, Inborn genetic diseases; not provided
- H34H (p.His34His), rs767627393, gnomAD 12-11752518-T-C, CADD 12.10
- V35I (p.Val35Ile), rs2497702436, ClinGen CA384041716, ClinVar RCV003565352, Uncertain significance, not provided
- V35V (p.Val35Val), gnomAD 12-11752521-T-C, CADD 11.20
- P36L (p.Pro36Leu), gnomAD rs1866053075, REVEL 0.21, CADD 24.60
- V37M (p.Val37Met), ExAC rs752186257, TOPMed rs752186257, gnomAD rs752186257, REVEL 0.12, CADD 23.20, Conflicting interpretations, Inborn genetic diseases; not provided
- V37E (p.Val37Glu), gnomAD 12-11752526-T-A, REVEL 0.17, CADD 22.90
- V37G (p.Val37Gly), gnomAD 12-11752526-T-G, REVEL 0.17, CADD 22.80
- V37V (p.Val37Val), gnomAD 12-11752527-G-A, CADD 12.10
- P38S (p.Pro38Ser), TOPMed rs1866053231, REVEL 0.10, CADD 21.80
- R39* (p.Arg39Ter), rs1036410712, NCI-TCGA Cosmic COSV6715, TOPMed rs1036410712, CADD 36.00, Variant assessed as somatic; high impact.
- R39Q (p.Arg39Gln), rs144209028, ClinGen CA6454118, ClinVar RCV002272847, ClinVar RCV003101544, REVEL 0.07, CADD 22.90, Conflicting interpretations, Thrombocytopenia 5; Inborn genetic diseases; not provided
- R39R (p.Arg39Arg), gnomAD 12-11752533-A-T, CADD 13.50
- A40T (p.Ala40Thr), Ensembl rs930627928, MetaLR 0.04, MetaSVM -1.04, Uncertain significance, Inborn genetic diseases
- A40V (p.Ala40Val), rs576945965, ClinGen CA6454119, ClinVar RCV002938965, ClinVar RCV003151428, REVEL 0.08, CADD 22.30, Benign/Likely benign, Thrombocytopenia 5; not provided; Inborn genetic diseases
- A40A (p.Ala40Ala), rs1408630798, gnomAD 12-11752536-G-A, CADD 11.40
- L41H (p.Leu41His), ExAC rs746847704, gnomAD rs746847704, REVEL 0.20, CADD 22.50
- L41F (p.Leu41Phe), gnomAD 12-11752537-C-T, REVEL 0.12, CADD 19.20
- R42G (p.Arg42Gly), rs199863871, ClinGen CA6454121, ClinVar RCV004383180, ExAC rs199863871, REVEL 0.22, CADD 25.50, Uncertain significance, Inborn genetic diseases
- R42K (p.Arg42Lys), TOPMed rs1866054362
- R42T (p.Arg42Thr), gnomAD 12-11752541-G-C, REVEL 0.27, CADD 26.60
- R42R (p.Arg42Arg), rs1054923515, gnomAD 12-11752542-G-A, CADD 14.10
- E44K (p.Glu44Lys), TOPMed rs1048824819, gnomAD rs1048824819, REVEL 0.19, CADD 25.20, Uncertain significance, Inborn genetic diseases
- E44Q (p.Glu44Gln), gnomAD 12-11752546-G-C, REVEL 0.11, CADD 24.90
- E45K (p.Glu45Lys), gnomAD rs1441890339, REVEL 0.16, CADD 25.70, Uncertain significance, Inborn genetic diseases
- D46A (p.Asp46Ala), Ensembl rs1591650029
- D46H (p.Asp46His), NCI-TCGA Cosmic COSV6714, MetaLR 0.10, MetaSVM -1.12, Variant assessed as somatic; moderate impact.
- D46N (p.Asp46Asn), Ensembl rs2121068121, REVEL 0.10, CADD 25.90, Uncertain significance, Inborn genetic diseases
- S47A (p.Ser47Ala), rs781022272, ClinGen CA384041832, ClinVar RCV003302652, ClinVar RCV006472334, REVEL 0.04, CADD 18.60, Uncertain significance, Inborn genetic diseases; not provided
- S47L (p.Ser47Leu), ExAC rs745855585, TOPMed rs745855585, gnomAD rs745855585, REVEL 0.05, CADD 23.20, Likely benign, Inborn genetic diseases
- S47P (p.Ser47Pro), ExAC rs781022272, TOPMed rs781022272, gnomAD rs781022272, REVEL 0.20, CADD 17.90, Uncertain significance
- S47R (p.Ser47Arg), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.07, Variant assessed as somatic; high impact.
- S47S (p.Ser47Ser), gnomAD 12-11752557-G-T, CADD 13.60
- I48F (p.Ile48Phe), ExAC rs775555383, REVEL 0.10, CADD 20.80
- I48G (p.Ile48Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I48L (p.Ile48Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I48M (p.Ile48Met), ExAC rs762963642, gnomAD rs762963642, REVEL 0.06, CADD 21.30
- I48N (p.Ile48Asn), NCI-TCGA TCGA novel, MetaLR 0.06, MetaSVM -1.08, Variant assessed as somatic; high impact.
- R49C (p.Arg49Cys), rs768891310, ClinGen CA6454127, NCI-TCGA Cosmic COSV1011, ClinVar RCV002508731, REVEL 0.15, AlphaMissense 0.16, Uncertain significance, Inborn genetic diseases; Thrombocytopenia 5; not provided
- R49H (p.Arg49His), rs1007158603, ClinVar RCV004560256, ClinVar RCV005638665, ClinVar RCV006368243, REVEL 0.04, CADD 23.10, Conflicting interpretations, not provided; Inborn genetic diseases
- R49L (p.Arg49Leu), TOPMed rs1007158603, gnomAD rs1007158603, REVEL 0.15, CADD 24.20, Uncertain significance, Inborn genetic diseases
- R49S (p.Arg49Ser), rs768891310, ClinGen CA384041840, ClinVar RCV003563347, ClinVar RCV005333627, AlphaMissense 0.16, MetaLR 0.12, Uncertain significance, not provided; Inborn genetic diseases
- R49R (p.Arg49Arg), gnomAD 12-11752563-C-T, CADD 13.50
- L50L (p.Leu50Leu), rs1292426806, gnomAD 12-11752566-G-A, CADD 11.90
- P51S (p.Pro51Ser), gnomAD 12-11752567-C-T, REVEL 0.33, CADD 26.30
- P51A (p.Pro51Ala), gnomAD 12-11752567-C-G, REVEL 0.32, CADD 25.40
- P51H (p.Pro51His), gnomAD 12-11752568-C-A, REVEL 0.39, MetaLR 0.26
- P51L (p.Pro51Leu), gnomAD 12-11752568-C-T, REVEL 0.45, MetaLR 0.26
- P51P (p.Pro51Pro), gnomAD 12-11752569-T-G, CADD 11.00
- A52E (p.Ala52Glu), ExAC rs774396176, TOPMed rs774396176, gnomAD rs774396176, REVEL 0.18, CADD 24.10, Uncertain significance
- A52T (p.Ala52Thr), TOPMed rs1457251241, gnomAD rs1457251241, REVEL 0.06, CADD 22.60, Uncertain significance, Inborn genetic diseases
- A52V (p.Ala52Val), rs774396176, ClinGen CA6454128, ClinVar RCV003332770, ClinVar RCV005554932, REVEL 0.07, CADD 22.90, Conflicting interpretations, not provided; Inborn genetic diseases; not specified
- A52S (p.Ala52Ser), gnomAD 12-11752570-G-T, REVEL 0.09, MetaLR 0.06
- A52A (p.Ala52Ala), rs762064732, gnomAD 12-11752572-G-A, CADD 12.50
- H53R (p.His53Arg), rs1866055526, ClinGen CA384041866, ClinVar RCV002293717, ClinVar RCV005333240, REVEL 0.12, CADD 21.60, Uncertain significance, Inborn genetic diseases; not provided
- H53Y (p.His53Tyr), NCI-TCGA Cosmic COSV6714, REVEL 0.23, CADD 23.60, Uncertain significance, Inborn genetic diseases
- H53H (p.His53His), rs1252021275, gnomAD 12-11752575-C-T, CADD 12.90
- L54M (p.Leu54Met), NCI-TCGA TCGA novel, MetaLR 0.23, MetaSVM -0.71, Variant assessed as somatic; moderate impact.
- L54L (p.Leu54Leu), gnomAD 12-11752576-C-T, CADD 13.30
- L54V (p.Leu54Val), gnomAD 12-11752576-C-G, REVEL 0.23, MetaLR 0.15
- R55C (p.Arg55Cys), rs750795092, NCI-TCGA Cosmic COSV6714, ExAC rs750795092, REVEL 0.25, CADD 25.10, Uncertain significance, not provided; Inborn genetic diseases
- R55L (p.Arg55Leu), TOPMed rs1378660612, gnomAD rs1378660612, REVEL 0.23, CADD 32.00
- R55S (p.Arg55Ser), gnomAD 12-11752579-C-A, REVEL 0.20, MetaLR 0.09
- R55P (p.Arg55Pro), gnomAD 12-11839140-G-C, REVEL 0.28, MetaLR 0.11
- L56F (p.Leu56Phe), gnomAD rs1278146731, REVEL 0.08, CADD 23.60
- L56S (p.Leu56Ser), NCI-TCGA Cosmic COSV1011, REVEL 0.28, CADD 27.80, Variant assessed as somatic; moderate impact.
- L56L (p.Leu56Leu), gnomAD 12-11839142-T-C, CADD 15.80
- Q57H (p.Gln57His), ExAC rs761341064, gnomAD rs761341064, REVEL 0.28, CADD 24.60, Uncertain significance, Inborn genetic diseases
- P58P (p.Pro58Pro), rs750118818, gnomAD 12-11839150-A-C, CADD 6.57
- Y60H (p.Tyr60His), gnomAD 12-11839154-T-C, REVEL 0.17, MetaLR 0.03
- W61C (p.Trp61Cys), gnomAD 12-11839159-G-C, REVEL 0.86, MetaLR 0.87
- S62R (p.Ser62Arg), ExAC rs755742361, gnomAD rs755742361, REVEL 0.70, CADD 28.10
- S62S (p.Ser62Ser), gnomAD 12-11839162-C-T, CADD 13.10
- D65E (p.Asp65Glu), NCI-TCGA Cosmic COSV6715, MetaLR 0.19, MetaSVM -0.84, Variant assessed as somatic; moderate impact.
- D65D (p.Asp65Asp), rs553200577, gnomAD 12-11839171-C-T, CADD 11.10
- V66G (p.Val66Gly), NCI-TCGA Cosmic COSV6714, MetaLR 0.53, MetaSVM 0.27, Variant assessed as somatic; moderate impact.
- V66I (p.Val66Ile), rs139975161, ClinGen CA6454181, NCI-TCGA Cosmic COSV6715, ClinVar RCV001822490, REVEL 0.40, CADD 24.60, Uncertain significance, not specified; Inborn genetic diseases; not provided
- A67D (p.Ala67Asp), rs2497924896, ClinGen CA384042604, ClinVar RCV003572000, ClinVar RCV005567548, REVEL 0.23, CADD 23.20, Uncertain significance, Inborn genetic diseases; not provided
- A67A (p.Ala67Ala), rs143451658, gnomAD 12-11839177-C-G, CADD 12.70
- Q68H (p.Gln68His), rs202004830, 1000Genomes rs202004830, ExAC rs202004830, TOPMed rs202004830, REVEL 0.10, CADD 21.50, Likely benign, Inborn genetic diseases
- Q68Q (p.Gln68Gln), gnomAD 12-11839180-G-A, CADD 9.83
- W69* (p.Trp69Ter), TOPMed rs1251762165, gnomAD rs1251762165, NCI-TCGA TCGA novel, CADD 39.00, Variant assessed as somatic; high impact.
- L70F (p.Leu70Phe), Ensembl rs1565546078, REVEL 0.44, CADD 25.70
- L70L (p.Leu70Leu), rs1453904386, gnomAD 12-11839186-C-T, CADD 11.60
- K71R (p.Lys71Arg), TOPMed rs1316503906, gnomAD rs1316503906, REVEL 0.09, CADD 20.50
- W72* (p.Trp72Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- W72G (p.Trp72Gly), Ensembl rs72550776, MetaLR 0.34, MetaSVM -0.19
- A73S (p.Ala73Ser), gnomAD rs1172244238, REVEL 0.32, CADD 27.00, Uncertain significance, not provided; Inborn genetic diseases
- N75N (p.Asn75Asn), rs1366070827, gnomAD 12-11839201-T-C, CADD 7.53
- E76* (p.Glu76Ter), rs121434637, ClinGen CA280127, ClinVar RCV000009547, Ensembl rs121434637, Pathogenic
Public ETV6 analysis runs
- ETV6 analysis run — ETV6 (888 variants) — completed 2026-08-19